Number of studies: k = 8
Number of treatments: n = 8
Number of pairwise comparisons: m = 12
Number of designs: d = 7

Fixed effects model

Treatment estimate (sm = 'OR'):
             daridorexant doxepin lemborexant placebo ramelteon seltorexant zolpidem zopiclone
daridorexant            .  0.3544      1.1224  0.8947    0.9895      0.9999   0.8393    0.3329
doxepin            2.8219       .      3.1674  2.5248    2.7923      2.8217   2.3686    0.9394
lemborexant        0.8909  0.3157           .  0.7971    0.8816      0.8909   0.7478    0.2966
placebo            1.1177  0.3961      1.2545       .    1.1060      1.1176   0.9381    0.3721
ramelteon          1.0106  0.3581      1.1343  0.9042         .      1.0105   0.8483    0.3364
seltorexant        1.0001  0.3544      1.1225  0.8948    0.9896           .   0.8394    0.3329
zolpidem           1.1914  0.4222      1.3373  1.0659    1.1789      1.1913        .    0.3966
zopiclone          3.0041  1.0646      3.3719  2.6877    2.9726      3.0039   2.5215         .

Lower 95%-confidence limit:
             daridorexant doxepin lemborexant placebo ramelteon seltorexant zolpidem zopiclone
daridorexant            .  0.0124      0.0492  0.2199    0.1687      0.1212   0.1392    0.0467
doxepin            0.0984       .      0.0507  0.1197    0.1101      0.0784   0.0725    0.0263
lemborexant        0.0391  0.0050           .  0.0487    0.0441      0.0306   0.0285    0.0103
placebo            0.2748  0.0188      0.0767       .    0.3765      0.1699   0.1728    0.0574
ramelteon          0.1723  0.0141      0.0568  0.3078         .      0.1154   0.1141    0.0389
seltorexant        0.1212  0.0098      0.0386  0.1360    0.1130           .   0.1667    0.0550
zolpidem           0.1975  0.0129      0.0510  0.1963    0.1586      0.2366        .    0.1795
zopiclone          0.4214  0.0298      0.1169  0.4149    0.3439      0.4964   1.1414         .

Upper 95%-confidence limit:
             daridorexant doxepin lemborexant placebo ramelteon seltorexant zolpidem zopiclone
daridorexant            . 10.1628     25.5933  3.6394    5.8038      8.2525   5.0628    2.3729
doxepin           80.9294       .    198.0571 53.2461   70.8411    101.6168  77.4117   33.5569
lemborexant       20.3148 19.7415           . 13.0343   17.6165     25.9069  19.6111    8.5508
placebo            4.5466  8.3532     20.5145       .    3.2484      7.3528   5.0947    2.4104
ramelteon          5.9276  9.0857     22.6674  2.6557         .      8.8525   6.3053    2.9080
seltorexant        8.2538 12.7626     32.6437  5.8866    8.6690           .   4.2267    2.0146
zolpidem           7.1863 13.7984     35.0700  5.7887    8.7631      5.9986        .    0.8761
zopiclone         21.4143 38.0291     97.2196 17.4125   25.6953     18.1784   5.5703         .

Random effects model

Treatment estimate (sm = 'OR'):
             daridorexant doxepin lemborexant placebo ramelteon seltorexant zolpidem zopiclone
daridorexant            .  0.3574      1.1319  0.9023    0.9677      1.0042   0.8459    0.3355
doxepin            2.7983       .      3.1674  2.5248    2.7078      2.8101   2.3670    0.9387
lemborexant        0.8835  0.3157           .  0.7971    0.8549      0.8872   0.7473    0.2964
placebo            1.1083  0.3961      1.2545       .    1.0725      1.1130   0.9375    0.3718
ramelteon          1.0334  0.3693      1.1697  0.9324         .      1.0378   0.8741    0.3467
seltorexant        0.9958  0.3559      1.1272  0.8985    0.9636           .   0.8423    0.3341
zolpidem           1.1822  0.4225      1.3381  1.0666    1.1440      1.1872        .    0.3966
zopiclone          2.9809  1.0653      3.3741  2.6895    2.8845      2.9935   2.5215         .

Lower 95%-confidence limit:
             daridorexant doxepin lemborexant placebo ramelteon seltorexant zolpidem zopiclone
daridorexant            .  0.0119      0.0471  0.2123    0.1538      0.1142   0.1343    0.0430
doxepin            0.0929       .      0.0482  0.1158    0.1014      0.0740   0.0694    0.0245
lemborexant        0.0368  0.0048           .  0.0470    0.0405      0.0288   0.0272    0.0095
placebo            0.2608  0.0182      0.0740       .    0.3446      0.1614   0.1678    0.0530
ramelteon          0.1642  0.0138      0.0554  0.2996         .      0.1105   0.1113    0.0364
seltorexant        0.1133  0.0094      0.0366  0.1303    0.1026           .   0.1583    0.0498
zolpidem           0.1877  0.0124      0.0487  0.1909    0.1456      0.2232        .    0.1592
zopiclone          0.3823  0.0278      0.1086  0.3836    0.3028      0.4458   1.0124         .

Upper 95%-confidence limit:
             daridorexant doxepin lemborexant placebo ramelteon seltorexant zolpidem zopiclone
daridorexant            . 10.7609     27.1953  3.8350    6.0885      8.8284   5.3264    2.6161
doxepin           84.2610       .    208.0362 55.0522   72.2935    106.7277  80.7524   35.9666
lemborexant       21.2256 20.7362           . 13.5169   18.0497     27.3004  20.5159    9.2050
placebo            4.7109  8.6365     21.2740       .    3.3378      7.6756   5.2375    2.6066
ramelteon          6.5019  9.8595     24.6965  2.9017         .      9.7480   6.8667    3.3029
seltorexant        8.7542 13.5156     34.6847  6.1960    9.0515           .   4.4809    2.2431
zolpidem           7.4440 14.4130     36.7366  5.9588    8.9865      6.3155        .    0.9878
zopiclone         23.2454 40.8141    104.7962 18.8546   27.4821     20.1003   6.2801         .

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0532; tau = 0.2307; I^2 = 4.1% [0.0%; 85.3%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                   Q d.f. p-value
Total           3.13    3  0.3721
Within designs  2.32    1  0.1275
Between designs 0.81    2  0.6681
[1] "A total of 8 treatments are included in the network."
[1] "A total of 8 studies are included in this analysis."
[1] "Estimated heterogeneity tau-squared0.05"
[1] "Global test for inconsistency, p-value 0.66812 (Q=1, d.o.f. 2)"
[1] "File created by E. G. Ostinelli on 2022-01-01"
